<?xml version="1.0" encoding="UTF-8"?>
<html xmlns="http://www.w3.org/1999/xhtml">
 <head charset="UTF-8"/>
 <style> * { font-family : helvetica;} .font16 { font-size : 16; } .font10 { font-size : 10; } .font11 { font-size : 11; } .font12 { font-size : 12; } .font29 { font-size : 29; } .font13 { font-size : 13; } .font30 { font-size : 30; } .font15 { font-size : 15; }</style>
 <body>
  <p>
   <span class="font30">the </span>
   <span class="font29">and </span>
   <span class="font16">for </span>
   <span class="font16">[]. </span>
   <span class="font15">with </span>
   <span class="font13">COVID- </span>
   <span class="font13">are </span>
   <span class="font13">SARS-CoV </span>
   <span class="font13">that </span>
   <span class="font12">viral </span>
   <span class="font12">from </span>
   <span class="font12">{background </span>
   <span class="font12">cell </span>
   <span class="font12">infection </span>
   <span class="font12">may </span>
   <span class="font12">patients </span>
   <span class="font12">virus </span>
   <span class="font11">treatment </span>
   <span class="font11">antibodies </span>
   <span class="font11">margin </span>
   <span class="font11">was </span>
   <span class="font11">vaccine </span>
   <span class="font11">{border-style </span>
   <span class="font11">The </span>
   <span class="font11">[,]. </span>
   <span class="font11">neutralizing </span>
   <span class="font11">px;} </span>
   <span class="font11">#ffffff;} </span>
   <span class="font11">can </span>
   <span class="font11">efficacy </span>
   <span class="font11">have </span>
   <span class="font11">receptor </span>
   <span class="font11">vaccines </span>
   <span class="font11">CoV </span>
   <span class="font11">Coronavirus </span>
   <span class="font11">binding </span>
   <span class="font11">disease </span>
   <span class="font11">has </span>
   <span class="font11">this </span>
   <span class="font11">clinical </span>
   <span class="font11">coronavirus </span>
   <span class="font11">human </span>
   <span class="font11">immune </span>
   <span class="font11">other </span>
   <span class="font11">severe </span>
   <span class="font11">were </span>
   <span class="font11">This </span>
   <span class="font11">against </span>
   <span class="font11">host </span>
   <span class="font11">novel </span>
   <span class="font11">such </span>
   <span class="font11">RNA </span>
   <span class="font11">Respiratory </span>
   <span class="font11">cells </span>
   <span class="font10">ACE </span>
   <span class="font10">These </span>
   <span class="font10">inhibitors </span>
   <span class="font10">its </span>
   <span class="font10">Severe </span>
   <span class="font10">activity </span>
   <span class="font10">also </span>
   <span class="font10">antibody </span>
   <span class="font10">antiviral </span>
   <span class="font10">been </span>
   <span class="font10">early </span>
   <span class="font10">effective </span>
   <span class="font10">not </span>
   <span class="font10">plasma </span>
   <span class="font10">potential </span>
   <span class="font10">responses </span>
   <span class="font10">Acute </span>
   <span class="font10">Angiotensin </span>
   <span class="font10">SARS </span>
   <span class="font10">Syndrome </span>
   <span class="font10">[,] </span>
   <span class="font10">already </span>
   <span class="font10">based </span>
   <span class="font10">currently </span>
   <span class="font10">development </span>
   <span class="font10">drug </span>
   <span class="font10">mAbs </span>
   <span class="font10">monoclonal </span>
   <span class="font10">pneumonia </span>
   <span class="font10">protein </span>
   <span class="font10">replication </span>
   <span class="font10">respiratory </span>
   <span class="font10">specific </span>
   <span class="font10">their </span>
   <span class="font10">therapy </span>
   <span class="font10">trials </span>
   <span class="font10">IFN </span>
   <span class="font10">S-protein </span>
   <span class="font10">drugs </span>
   <span class="font10">especially </span>
   <span class="font10">functional </span>
   <span class="font10">fusion </span>
   <span class="font10">hydroxychloroquine </span>
   <span class="font10">into </span>
   <span class="font10">low </span>
   <span class="font10">px; </span>
   <span class="font10">response </span>
   <span class="font10">safety </span>
   <span class="font10">studies </span>
   <span class="font10">thus </span>
   <span class="font10">use </span>
   <span class="font10">{font-family </span>
   <span class="font10">Chinese </span>
   <span class="font10">DNA </span>
   <span class="font10">Patients </span>
   <span class="font10">SARS-CoV- </span>
   <span class="font10">With </span>
   <span class="font10">administration </span>
   <span class="font10">animal </span>
   <span class="font10">control </span>
   <span class="font10">cytokine </span>
   <span class="font10">different </span>
   <span class="font10">entry </span>
   <span class="font10">font-size </span>
   <span class="font10">infection. </span>
   <span class="font10">infections </span>
   <span class="font10">molecules </span>
   <span class="font10">proteins </span>
   <span class="font10">since </span>
   <span class="font10">spike </span>
   <span class="font10">through </span>
   <span class="font10">under </span>
   <span class="font10">used </span>
   <span class="font10">viruses </span>
   <span class="font10">COVID-: </span>
   <span class="font10">Convalescent </span>
   <span class="font10">Microbes </span>
   <span class="font10">Phase </span>
   <span class="font10">RBD </span>
   <span class="font10">Treatment </span>
   <span class="font10">affect </span>
   <span class="font10">affected </span>
   <span class="font10">after </span>
   <span class="font10">assessed </span>
   <span class="font10">associated </span>
   <span class="font10">blood </span>
   <span class="font10">convalescent </span>
   <span class="font10">could </span>
   <span class="font10">days </span>
   <span class="font10">detected </span>
   <span class="font10">double; </span>
   <span class="font10">effects </span>
   <span class="font10">emerging </span>
   <span class="font10">humoral </span>
   <span class="font10">immunity </span>
   <span class="font10">increased </span>
   <span class="font10">infected </span>
   <span class="font10">most </span>
   <span class="font10">recent </span>
   <span class="font10">reduce </span>
   <span class="font10">results </span>
   <span class="font10">target </span>
   <span class="font10">therapeutic </span>
   <span class="font10">trial </span>
   <span class="font10">Engl. </span>
   <span class="font10">Further, </span>
   <span class="font10">IL- </span>
   <span class="font10">Infect../.. </span>
   <span class="font10">Rev. </span>
   <span class="font10">Wuhan, </span>
   <span class="font10">al. </span>
   <span class="font10">and/or </span>
   <span class="font10">border-color </span>
   <span class="font10">border-width </span>
   <span class="font10">causing </span>
   <span class="font10">combination </span>
   <span class="font10">critical </span>
   <span class="font10">cytokines </span>
   <span class="font10">domain </span>
   <span class="font10">highly </span>
   <span class="font10">including </span>
   <span class="font10">infectious </span>
   <span class="font10">outbreak </span>
   <span class="font10">preclinical </span>
   <span class="font10">produced </span>
   <span class="font10">rate </span>
   <span class="font10">recently </span>
   <span class="font10">regard, </span>
   <span class="font10">should </span>
   <span class="font10">solid; </span>
   <span class="font10">strategies </span>
   <span class="font10">study </span>
   <span class="font10">symptoms </span>
   <span class="font10">syndrome </span>
   <span class="font10">system </span>
   <span class="font10">targeting </span>
   <span class="font10">there </span>
   <span class="font10">time </span>
   <span class="font10">undertaken </span>
   <span class="font10">vector </span>
   <span class="font10">{font-style </span>
   <span class="font10">{font-weight </span>
   <span class="font10">(NCT) </span>
   <span class="font10">China </span>
   <span class="font10">Chloroquine </span>
   <span class="font10">Disease </span>
   <span class="font10">Furthermore, </span>
   <span class="font10">HCQ </span>
   <span class="font10">Indeed, </span>
   <span class="font10">June </span>
   <span class="font10">KRA; </span>
   <span class="font10">Lab. </span>
   <span class="font10">Patents </span>
   <span class="font10">Review </span>
   <span class="font10">Type </span>
   <span class="font10">University </span>
   <span class="font10">Vaccines </span>
   <span class="font10">[], </span>
   <span class="font10">accessed </span>
   <span class="font10">acid </span>
   <span class="font10">activities </span>
   <span class="font10">administered </span>
   <span class="font10">all </span>
   <span class="font10">aminotransferase </span>
   <span class="font10">amplification </span>
   <span class="font10">anti-CoV </span>
   <span class="font10">anti-inflammatory </span>
   <span class="font10">antibodies. </span>
   <span class="font10">antigen </span>
   <span class="font10">being </span>
   <span class="font10">bold </span>
   <span class="font10">but </span>
   <span class="font10">courier; </span>
   <span class="font10">demonstrated </span>
   <span class="font10">drugs, </span>
   <span class="font10">due </span>
   <span class="font10">during </span>
   <span class="font10">em; </span>
   <span class="font10">epitopes </span>
   <span class="font10">first </span>
   <span class="font10">generate </span>
   <span class="font10">generated </span>
   <span class="font10">glycoprotein </span>
   <span class="font10">group </span>
   <span class="font10">high </span>
   <span class="font10">however, </span>
   <span class="font10">identification </span>
   <span class="font10">identify </span>
   <span class="font10">inflammatory </span>
   <span class="font10">interferons </span>
   <span class="font10">investigation </span>
   <span class="font10">isothermal </span>
   <span class="font10">leading </span>
   <span class="font10">levels </span>
   <span class="font10">lopinavir, </span>
   <span class="font10">lower </span>
   <span class="font10">management </span>
   <span class="font10">measures </span>
   <span class="font10">mechanisms </span>
   <span class="font10">ongoing </span>
   <span class="font10">particles </span>
   <span class="font10">patient </span>
   <span class="font10">peptide </span>
   <span class="font10">peripheral </span>
   <span class="font10">present </span>
   <span class="font10">preventive </span>
   <span class="font10">production </span>
   <span class="font10">pt;} </span>
   <span class="font10">receptors </span>
   <span class="font10">reduced </span>
   <span class="font10">risk </span>
   <span class="font10">ritonavir, </span>
   <span class="font10">several </span>
   <span class="font10">similar </span>
   <span class="font10">stage </span>
   <span class="font10">started </span>
   <span class="font10">storm </span>
   <span class="font10">than </span>
   <span class="font10">those </span>
   <span class="font10">titers </span>
   <span class="font10">tract </span>
   <span class="font10">using </span>
   <span class="font10">vaccination </span>
   <span class="font10">virus, </span>
   <span class="font10">virus. </span>
   <span class="font10">when </span>
   <span class="font10">which </span>
   <span class="font10">will </span>
   <span class="font10">within </span>
  </p>
 </body>
</html>
